When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Sofosbuvir/velpatasvir - Wikipedia

   en.wikipedia.org/wiki/Sofosbuvir/velpatasvir

   Sofosbuvir/velpatasvir was developed by the pharmaceutical company Gilead Sciences and approved by the U.S. Food and Drug Administration (FDA) in June 2016. [13] In the European Union it was approved in July 2016, for the treatment of chronic hepatitis C virus infection in adults.

3. Viloxazine - Wikipedia

   en.wikipedia.org/wiki/Viloxazine

   Viloxazine is indicated to treat attention deficit hyperactivity disorder (ADHD) in children age 6 to 12 years, adolescents age 13 to 17 years, and adults. [1]Analyses of clinical trial data suggest that viloxazine produces moderate reductions in symptoms; it is about as effective as atomoxetine and methylphenidate but with fewer side effects.

4. Management of attention deficit hyperactivity disorder

   en.wikipedia.org/wiki/Management_of_attention...

   Initially the drug was used to treat narcolepsy, chronic fatigue, depression, and to counter the sedating effects of other medications. The drug began to be used for ADHD in the 1960s and steadily rose in use. [223] In 1975, pemoline (Cylert) was approved by the U.S. FDA for use in the treatment of ADHD. While an effective agent for managing ...

5. First over-the-counter birth control pill gets FDA approval

   www.aol.com/news/first-over-counter-birth...

   Federal regulators on Thursday approved the nation's first over-the-counter birth control pill in a landmark decision that will soon allow American women and girls to obtain contraceptive ...

6. The FDA Just Approved Opill, the First Over-the-Counter Birth ...

   www.aol.com/fda-just-approved-opill-first...

   The FDA approved the first over-the-counter birth control pill—Opill—in a landmark feat. Here's everything you need to know about it.

7. Selective norepinephrine reuptake inhibitor - Wikipedia

   en.wikipedia.org/wiki/Selective_norepinephrine...

   After 2–4 weeks the dose can be increased to 100 mg/ daily. [23] In the use of reboxetine for depression, clinical studies have shown that most patients are treated with an initial dose of reboxetine 8 mg/day, most often as a divided dose. Depending upon patient tolerance and need, the dose can be increased up to 10 mg/day.